Inhibiting mutant IDH-1
Abstract:
Methods of treating patients diagnosed with cancer harboring an IDH-1 mutation are provided, including the therapeutic administration of a certain inhibitor of a mutant IDH-1 as a single agent, or in combination with azacitidine (AZA).
Public/Granted literature
Information query
Patent Agency Ranking
0/0